Abstract
Substantial progress has been achieved in the last two decades with the implementation of measles control strategies in the African Region. Elimination of measles is defined as the absence of endemic transmission in a defined geographical region or country for at least 12 months, as documented by a well-performing surveillance system. The framework for documenting elimination outlines five lines of evidence that should be utilized in documenting and assessing progress towards measles elimination. In March 2017, the WHO regional office for Africa developed and disseminated regional guidelines for the verification of measles elimination. As of May 2019, fourteen countries in the African Region have established national verification committees and 8 of these have begun to document progress toward measles elimination. Inadequate awareness, concerns about multiple technical committees for immunization work, inadequate funding and human resources, as well as gaps in data quality and in the implementation of measles elimination strategies have been challenges that hindered the establishment and documentation of progress by national verification committees. We recommend continuous capacity building and advocacy, technical assistance and networking to improve the work around the documentation of country progress towards measles elimination in the African Region.
Highlights
The WHO global vaccine action plan 2011-2020 outlines a goal for the elimination of measles and rubella in at least 5 WHO regions by 2020 [1]
Elimination of measles is defined as the absence of endemic transmission in a defined geographical region or country for at least 12 months, as documented by a well-performing surveillance system
We recommend continuous capacity building and advocacy, technical assistance and networking to improve the work around the documentation of country progress towards measles elimination in the African Region
Summary
Balcha Masresha1,&, Richard Luce Jr2, Patricia Tanifum, Emmaculate Lebo, Annick Dosseh, Richard Mihigo1 1WHO Regional Office for Africa, Brazzaville, Congo, 2WHO, Inter-country team for Western Africa, Ouagadougou, Burkina Faso, 3WHO, Inter-country team for Central Africa, Libreville, Gabon, 4WHO, Inter-country team for Eastern and Southern Africa, Harare, Zimbabwe &Corresponding author: Balcha Masresha, WHO Regional Office for Africa, Brazzaville, Congo. This article is published as part of the supplement “Innovations in measles and rubella elimination” sponsored by the PAMJ Guest editors: Robert Davis, James Goodson, Raoul Kamadjeu Available online at: http://www.panafrican-med-journal.com/content/series/35/1/1/full
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.